Glycemic profile assessment during betamethasone administration in women with twin pregnancies after IVF with or without gestational diabetes

Diabetes Metab Syndr. 2022 Jun;16(6):102534. doi: 10.1016/j.dsx.2022.102534. Epub 2022 Jun 6.

Abstract

Background and aims: Betamethasone's effect on glycemia in twin pregnancies, with or without gestational diabetes mellitus, has not been adequately investigated.

Methods: We assessed the glycemic profile of 30 women with twin pregnancies after in-vitro-fertilization who were given betamethasone.

Results: The majority of women were treated eventually with insulin to maintain glycemia. In insulin-treated women the increase in insulin dosage was of 61.1%. Insulin use/dosage was not associated with betamethasone dose, age, gestational age, weight gain in pregnancy, or duration of hyperglycemia.

Conclusion: Post-betamethasone, twin pregnancies seem to follow the same glycemia pattern as singleton pregnancies.

Keywords: Betamethasone; Gestational diabetes; IVF; Pregnancy; Twin pregnancies.

MeSH terms

  • Betamethasone / therapeutic use
  • Blood Glucose
  • Diabetes, Gestational* / drug therapy
  • Female
  • Fertilization in Vitro
  • Humans
  • Insulin / therapeutic use
  • Pregnancy
  • Pregnancy Outcome
  • Pregnancy, Twin
  • Retrospective Studies

Substances

  • Blood Glucose
  • Insulin
  • Betamethasone